These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25499450)

  • 21. Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma.
    Pittaluga S; Nicolae A; Wright GW; Melani C; Roschewski M; Steinberg S; Huang D; Staudt LM; Jaffe ES; Wilson WH
    Blood Cancer Discov; 2020 Sep; 1(2):155-161. PubMed ID: 32914098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging biological insights and novel treatment strategies in primary mediastinal large B-cell lymphoma.
    Dunleavy K; Steidl C
    Semin Hematol; 2015 Apr; 52(2):119-25. PubMed ID: 25805591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.
    Cheah CY; Hofman MS; Seymour JF; Ritchie DS; Dickinson M; Wirth A; Prince HM; Wolf M; Januszcewicz EH; Carney DA; Herbert KE; Harrison SJ; Burbury KL; Tam CS
    Leuk Lymphoma; 2015 Jan; 56(1):49-56. PubMed ID: 24724780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 2.
    Piña-Oviedo S; Moran CA
    Adv Anat Pathol; 2019 Nov; 26(6):371-389. PubMed ID: 31567129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Features and Therapeutic Outcomes Comparing Primary Mediastinal Large B-cell Lymphoma to Mediastinal Hodgkin Disease.
    Cruz-Chamorro RJ; Rodríguez-López JL; González-Soto MJ; Arroyo-Suárez R; Ortiz-Sánchez C; Encarnación-Medina J; Cabanillas F
    P R Health Sci J; 2024 Jun; 43(2):79-83. PubMed ID: 38860961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage therapy for relapsed mediastinal B-cell lymphoma with allogeneic HLA-identical related donor bone marrow transplantation, donor lymphocyte infusion and IDEC-C2B8.
    Ratei R; Matylis A; Krahl D; Arnold R; Stein H; Dörken B; Ludwig WD
    Leuk Lymphoma; 2000 Dec; 40(1-2):133-40. PubMed ID: 11426614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report: workshop on mediastinal grey zone lymphoma.
    Poppema S; Kluiver JL; Atayar C; van den Berg A; Rosenwald A; Hummel M; Lenze D; Lammert H; Stein H; Joos S; Barth T; Dyer M; Lichter P; Klein U; Cattoretti G; Gloghini A; Tu Y; Stolovitzky GA; Califano A; Carbone A; Dalla-Favera R; Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
    Eur J Haematol Suppl; 2005 Jul; (66):45-52. PubMed ID: 16007868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report.
    Zhang C; Yi Y; Chen C; Wang J; Liu Z
    Diagn Pathol; 2015 Dec; 10():215. PubMed ID: 26715530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.
    Lees C; Keane C; Gandhi MK; Gunawardana J
    Br J Haematol; 2019 Apr; 185(1):25-41. PubMed ID: 30740662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
    Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas.
    Singh K; Lezama LS; Kurzer J; Oak J; Schultz LM; Walkush A; Cheng TC; Chen EH; May WA; Chang C; Link MP; Advani RH; Suarez CJ; Natkunam Y
    Am J Surg Pathol; 2023 Jan; 47(1):81-90. PubMed ID: 36001451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 27 cases].
    Shi QY; Feng X; Chen H; Ma HH; Lu ZF; Shi QL; Zhou XJ; Shen Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):607-612. PubMed ID: 28910870
    [No Abstract]   [Full Text] [Related]  

  • 33. Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
    Nath SV; Seymour JF
    Leuk Lymphoma; 2005 Jul; 46(7):1075-9. PubMed ID: 16019561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hodgkin and non-Hodgkin lymphoma of adolescents and young adults].
    Garciaz S; Coso D; Brice P; Bouabdallah R
    Bull Cancer; 2016 Dec; 103(12):1035-1049. PubMed ID: 27866679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
    Hüttmann A; Rekowski J; Müller SP; Hertenstein B; Franzius C; Mesters R; Weckesser M; Kroschinsky F; Kotzerke J; Ganser A; Bengel FM; La Rosée P; Freesmeyer M; Höffkes HG; Hertel A; Behringer D; Prange-Krex G; Griesshammer M; Holzinger J; Wilop S; Krohn T; Raghavachar A; Maschmeyer G; Brink I; Schroers R; Gaska T; Bernhard H; Giagounidis A; Schütte J; Dienst A; Hautzel H; Naumann R; Klein A; Hahn D; Pöpperl G; Grube M; Marienhagen J; Schwarzer A; Kurch L; Höhler T; Steiniger H; Nückel H; Südhoff T; Römer W; Brinkmann M; Ose C; Alashkar F; Schmitz C; Dürig J; Hoelzer D; Jöckel KH; Klapper W; Dührsen U
    Ann Hematol; 2019 Apr; 98(4):897-907. PubMed ID: 30610279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
    Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation.
    Filippi AR; Piva C; Levis M; Chiappella A; Caracciolo D; Bellò M; Bisi G; Vitolo U; Ricardi U
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1239-43. PubMed ID: 27130796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.
    Zinzani PL; Piccaluga PP
    Curr Oncol Rep; 2011 Oct; 13(5):407-15. PubMed ID: 21789543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
    Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
    Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.